Literature DB >> 30524661

The Possible Pathophysiological Outcomes and Mechanisms of Tourniquet-Induced Ischemia-Reperfusion Injury during Total Knee Arthroplasty.

Prangmalee Leurcharusmee1,2,3, Passakorn Sawaddiruk1,2,3, Yodying Punjasawadwong2, Nipon Chattipakorn1,3, Siriporn C Chattipakorn1,3,4.   

Abstract

Ischemia and reperfusion (I/R) injury induced by tourniquet (TQ) application leads to the release of both oxygen free radicals and inflammatory cytokines. The skeletal muscle I/R may contribute to local skeletal muscle and remote organ damage affecting outcomes after total knee arthroplasty (TKA). The aim of the study is to summarize the current findings associated with I/R injury following TKA using a thigh TQ, which include cellular alterations and protective therapeutic interventions. The PubMed database was searched using the keywords "ischemia reperfusion injury," "oxidative stress," "tourniquet," and "knee arthroplasty." The search was limited to research articles published in the English language. Twenty-eight clinical studies were included in this qualitative review. Skeletal muscle I/R reduces protein synthesis, increases protein degradation, and upregulates genes in cell stress pathways. The I/R of the lower extremity elevates local and systemic oxidative stress as well as inflammatory reactions and impairs renal function. Propofol reduces oxidative injury in this I/R model. Ischemic preconditioning (IPC) and vitamin C may prevent oxygen free radical production. However, a high dose of N-acetylcysteine possibly induces kidney injury. In summary, TQ-related I/R during TKA leads to muscle protein metabolism alteration, endothelial dysfunction, oxidative stress, inflammatory response, and renal function disturbance. Propofol, IPC, and vitamin C show protective effects on oxidative and inflammatory markers. However, a relationship between biochemical parameters and postoperative clinical outcomes has not been validated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30524661      PMCID: PMC6247434          DOI: 10.1155/2018/8087598

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN: 1942-0994            Impact factor:   6.543


1. Introduction

Total knee arthroplasty (TKA) is a surgical treatment aiming at improving the mobility and quality of life of patients suffering from advanced knee osteoarthritis. The prevalence of this procedure has substantially increased in the past decade and is expected to continue [1, 2]. A hallmark of the clinical success of TKA is postoperative quadriceps muscle function. Muscle atrophy following a use of intraoperative thigh tourniquet (TQ) results in early postoperative deficits in quadriceps strength and subsequently impaired TKA rehabilitation. The majority of TKA patients are in the elderly population [1] whose TQ-induced muscle loss is likely permanent and may increase risk for falls as well as loss of independence [3]. A TQ is routinely used in extremity surgery to produce a bloodless surgical field. However, TQ application alters normal physiology and is associated with several complications [4]. Locally, a circumferential inflatable cuff compresses the structures beneath the cuff and can possibly cause mechanical and ischemic injuries to localized muscles and nerves. Skeletal muscles distal to the TQ are also affected at a molecular level by prolonged inadequate blood flow and subsequent restoration of circulation. Systemically, limb exsanguination followed by TQ inflation transiently increases central blood volume and systemic vascular resistance, induces a hypercoagulable state, and activates fibrinolytic activity. Clinically, the use of a TQ is considered a risk factor for thromboembolism [5]. However, the incidence of deep vein thrombosis and pulmonary thromboembolism after TKA was found to be similar regardless of the use of the TQ [6]. TQ inflation induces ischemia to an extremity, and its release may lead to an ischemia and reperfusion (I/R) injury to not only localized skeletal muscle but also systemic circulation and vital distant organs including the brain, heart, lungs, and kidneys. The restoration of blood flow following an ischemic period is essential to preventing irreversible cellular injury; however, the reperfusion can augment secondary damage to ischemia. During oxygen deprivation, intracellular ionic and metabolic changes including ATP depletion, intracellular acidosis, and cytosolic calcium overload occur and cause damage to cells [7]. In addition, ischemia can exacerbate reactive oxygen species (ROS) production and promote a proinflammatory state, which subsequently increases tissue vulnerability to further injury during reperfusion. Upon the reintroduction of oxygen, excessive production of ROS disproportionate to the antioxidant capacity results in cell injury through the oxidation of proteins, lipids, and DNA. Several treatment strategies have been proposed to prevent or attenuate the effects of I/R injury following TQ use in cases of orthopedic surgery [8]. Studies into the use of ischemic preconditioning (IPC) and antioxidants have generated inconclusive results depending on the administration techniques. Of the anesthetic agents, propofol is the best medication producing both antioxidative and anti-inflammatory effects. However, the correlation between the benefits of these interventional and pharmacologic strategies with the postoperative clinical outcomes has not been drawn. Therefore, the aim of this review is to summarize current findings relating to the effects of TQ-induced I/R injury on localized skeletal muscles, local and systemic circulation, and remote organs in TKA surgery and therapeutic interventions in clinical study. Furthermore, the controversial reports regarding these issues are included and discussed.

2. Effects of TQ-Induced I/R Injury on Localized Skeletal Muscles

TQ application during TKA has been shown to produce I/R injury in human skeletal muscle by triggering cascades of cellular events resulting in a reduction in protein synthesis [9], an increase in protein degradation [10, 11], and an upregulation of the genes in cell stress pathways [12]. Alterations in the protein metabolism as a result of I/R injury lead to the mobilization of free amino acids [11] which subsequently contribute to quadriceps muscle atrophy [3]. Cap-dependent translation initiation and elongation in the protein synthesis pathway were inhibited during ischemia and in early reperfusion phases causing downregulation of protein synthesis and a 12% loss of mid-thigh quadriceps volume as measured by magnetic resonance imaging (MRI) at two weeks after surgery [9]. The ubiquitin (Ub) proteasome system, the main pathway of skeletal muscle proteolysis, was upregulated at 60 minutes of ischemia suggesting an increase in muscle protein breakdown [10]. Regarding the analysis of gene expression profiles following TKA, 72 genes in skeletal muscle cells were significantly upregulated at two hours after TQ release [12]. The genes related to the cell stress pathways were altered and potentially induced apoptosis, cell cycle regulation, and complement activation. Other mechanisms of skeletal muscle I/R injury have been investigated [13, 14]. Many studies [15-17] have reported that endothelial dysfunction resulting from an imbalance of vasoactive substances, including endothelin 1 (ET-1), as well as neuronal and endothelial nitric oxide synthases (nNOS and eNOS) plays a role in the pathophysiology of several ischemic conditions. Concordantly, ET-1, nNOS, and eNOS are involved in skeletal muscle I/R. The rise in ET-1 tissue protein levels occurred during the periods of I/R and was attributed to an increase in the release of stored peptides or the conversion of precursor peptides to ET-1 [13]. Furthermore, the upregulation of NOSs occurred in postischemic skeletal muscle. The increased protein expression of nNOS was controlled at the mRNA level, whereas the upregulation of the eNOS protein was regulated by posttranscriptional processes [14]. All these findings suggest that agents modulating the ET-1 and NO pathways such as an ET antagonist may have therapeutic benefits in this condition. The cellular bioenergetics and mitochondria are preserved during skeletal muscle I/R in the TKA setting [11, 18, 19]. For example, (1) adenosine triphosphate (ATP) concentrations and mitochondrial enzymes were maintained during 60–90 minutes of ischemic time and at 24 hours after reperfusion [11, 18], despite significant metabolic changes which suggested ischemic injury to the skeletal muscle cell at approximately 75 minutes of ischemia [20], and (2) a previous human study [19] showed mitochondria to have normal appearance when viewed under an electron microscope after 15 minutes of ischemia. However, in cases of myocardial I/R condition, mitochondrial respiratory chain activity was reduced after 30 minutes of ischemia and restored upon reperfusion as a biphasic process [21, 22]. All those findings suggest that alterations in mitochondrial function induced by I/R injury are tissue-specific and the severity of the cellular damage depends on the duration of ischemia. However, the actual period of total ischemia which results in mitochondrial damage and the reversal time of mitochondrial dysfunction have not yet been validated. Therefore, the ischemic time inducing skeletal muscle mitochondrial impairment should be further defined and therapeutic strategies to address the prevention and modulation of mitochondrial injury should be studied. A comprehensive summary of those findings is shown in Table 1.
Table 1

Effects of TQ-induced I/R injury on localized skeletal muscles.

Study model/specimen/sample size/ageTQ pressure/ischemia timeMajor findings (compared to baseline level)InterpretationReferences
Clinical outcomeMechanism
Ischemia phaseReperfusion phase
Cross-sectional study/vastus lateralis muscle biopsy/n = 13/62–76 yr≥300 mmHg, 32–52 min↓ 12% of quadriceps muscle volume at 2 weeks after surgery↔ eIF4G gene expression↓ phosphorylation of Akt at Ser473 and 4E-BP1↑ phosphorylation of eEF2↑ eIF4G gene expression↓ phosphorylation of Akt at Ser473 and 4E-BP1↑ phosphorylation of eEF2Cap-dependent translation initiation and elongation may be inhibited during skeletal muscle I/R[9]
Randomized controlled trial/vastus medialis muscle biopsy/n = 34/55–85 yr380 mmHg, 60 minN/A↔ free, conjugated Ub↔ total Ub-protein ligase activity↑ proteasome-dependent and -independent peptidase activitiesN/AUpregulated proteasome-dependent and -independent peptidase activities suggested an increase in protein degradation at 60-minute ischemia time[10]
Randomized controlled trial/vastus lateralis muscle biopsy/n = 15/63–76 yrDouble SBP mmHg, 56–92 minN/A↑ all muscle-free amino acids, except glutamate↔ mitochondrial enzymes↓ all muscle-free amino acids↔ mitochondrial enzymesDegradation of free amino acids was more than synthesis during skeletal muscle ischemiaNo mitochondrial dysfunction occurred at maximum ischemia and at 24 hours after reperfusion[11]
Cross-sectional study/vastus lateralis muscle biopsy/n = 13/60–78 yr≥300 mmHg, 33–50 minN/AN/AUpregulation of 72 genes including JAK-STAT, p53, JNK, NFκB, Akt, and MAPKGenes related to cell stress pathways involved in reperfusion injury[12]
Cross-sectional study/quadriceps muscle biopsy, venous blood/n = 13/64–89 yr300 mmHgN/A↑ positive ET-1-immunostaining cells↔ ET-1 mRNA expression↔ plasma ET-1↑ positive ET-1-immunostaining cells↔ ET-1 mRNA expression↔ plasma ET-1ET-1 is involved in skeletal muscle I/R[13]
Cross-sectional study/quadriceps muscle biopsy/n = 12/64–89 yr300 mmHgN/A↔ nNOS, iNOS, and eNOS immunostaining in muscle fibers↑ nNOS mRNA expression↔ nNOS and eNOS protein expression↔ NOS activity↑ nNOS and eNOS immunostaining in muscle fibers↑ nNOS mRNA expression↑ nNOS and eNOS protein expression↔ NOS activitynNOS and eNOS were upregulated in postischemic muscle, but their activities were not altered[14]
Randomized controlled trial/interstitial space fluid at gastrocnemius muscle/n = 31/68 ± 8 yr250 mmHg, 74 ± 4 minN/A↓ glucose↓ pyruvate↑ lactate↑ L/P ratio↑ glycerol↓ glucose↑ pyruvate↑ lactate↔ L/P ratio↑ glycerolChanges in the level of metabolic markers in the extracellular space suggested ischemic injury and persisted for up to 180 minutes after reperfusion[20]
Randomized controlled trial/vastus medialis muscle biopsy/n = 10/74 ± 3 yr380 mmHg, 60 minN/A↔ mitochondrial enzymesN/ANo effects on amount and function of mitochondria at 60-minute ischemia time[18]

4E-BP1: eukaryotic initiation factor 4E-binding protein; eEF2: eukaryotic elongation factor 2; eIF4G: eukaryotic translation initiation factor 4 gamma; ET-1: endothelin 1; I/R: ischemia and reperfusion; JAK-STAT: Janus kinase/signal transducer and activator of transcription; JNK: c-Jun N-terminal kinase; L/P: lactate/pyruvate; MAPK: mitogen-activated protein kinase; mRNA: messenger ribonucleic acid; N/A: not available; NFκB: nuclear factor kappa-light-chain-enhancer of activated B cells; NOS: nitric oxide synthase; SBP: systolic blood pressure; TQ: tourniquet; Ub: ubiquitin.

3. Effects of TQ-Induced I/R Injury on Local and Systemic Circulation

TQ use can lead to a production of oxygen free radicals and stimulation of inflammatory processes in the ischemic skeletal muscle cells and endothelium. Upon TQ release, activated endothelial cells generate more oxygen free radicals and release inflammatory mediators [23]. The elevated oxidative stress levels and the inflammatory reaction in both the local and systemic circulation after TQ deflation were demonstrated in the TKA-related I/R models [24-26]. Interestingly, the changes were observed earlier and more intensely in the blood from the reperfused area than from the systemic circulation. The rise in systemic prooxidant and hypoxanthine levels as well as in xanthine oxidase activity is probably explained by a dispersal of these molecules from the injured area into the systemic circulation because hypoxanthine accumulates in hypoxic conditions [25]. On the other hand, the circulatory increase in pro- and anti-inflammatory cytokines can be explained by systemically induced stress responses secondary to tissue trauma. The number and type of lymphocytes can be used to monitor the systemic effect of the stress response, and the application of a TQ has been shown to induce genotoxic and cytotoxic effects on peripheral leukocytes during the reperfusion period with possible irreversible damage [27]. Despite these acknowledged deleterious effects of use of a TQ, the surgical trauma per se generates surgical stress which is characterized by neuroendocrine, immunological, and hematological changes. When compared to the procedure without TQ application, the increase in plasma interleukin-6 (IL-6), C-reactive protein (CRP), creatine phosphokinase (CPK) and white blood cell counts at 24 hours and seven days after surgery were not different and improvement of knee function at one year after operation was comparable [28]. It is possible that these long-term systemic responses originated from the surgical injury. Further studies focusing on differentiation between responses from surgical stress and those from I/R injury in this setting should be investigated. A comprehensive summary of those findings is shown in Table 2.
Table 2

Effects of TQ-induced I/R injury on local and systemic circulation.

Study model/specimen/sample size/ageTQ pressure/ischemia timeMain findings (compared to baseline level)InterpretationReferences
Clinical outcomeMechanism
Local circulationSystemic circulation
Randomized controlled trial/antecubital venous blood/n = 15/blood from surgical drain/n = 17/approx. 70 ± 7 yr250 mmHg, approx. 90 ± 15 minN/ASurgical drainage tube↓↓ GSH↑↑ GSSG↑↑ MDAAntecubital vein↓ GSH↑ GSSG↑ MDAChanges in glutathione oxidation and lipid peroxidation happened earlier and more intensely in the blood from the reperfused area than from the systemic circulation[24]
Cross-sectional study/antecubital and femoral venous blood/n = 10/69 ± 2 yrDouble SBP mmHg, 85 ± 8 minN/AFemoral vein of operated leg↑↑ hypoxanthine, XO activity, and xanthine↑ GSSG/GSHAntecubital vein↑ hypoxanthine, XO activity, and xanthine↔ GSSG/GSHHigher increase in prooxidants and oxidative stress in the blood from the reperfused area compared to the systemic circulation[25]
Cross-sectional study/great saphenous venous blood of both legs, blood from surgical drain/n = 9/57–71 yr250–300 mmHg, 78–125 minN/ASurgical drainage tube↑↑ IL-6↑ IL-10Great saphenous vein of nonoperated leg↑ IL-6↔ IL-10Higher increase in pro- and anti-inflammatory cytokines in the blood from the reperfused area compared to the systemic circulation[26]
Cross-sectional study/peripheral blood lymphocytes/n = 11/60–75 yr100–120 minN/AN/A↑ genotoxicity index↑ cytotoxicity index↔ cytostaticity indexGenotoxic and cytotoxic effects on peripheral lymphocytes were most pronounced at onset of reperfusion and remained so 1 hour afterward[27]
Case-control study/venous blood/n = 20/74 ± 7 yr250–300 mmHg, 80 ± 20 min↑ knee function scoresNo surgical site infection at 1 yrN/A↑ IL-6, CPR, CPK, and white cell countOxidative stress after TKA surgery primarily originated from surgical stress only[28]

CPK: creatine phosphokinase; CRP: c-reactive protein; GSH: reduced glutathione; GSSG: oxidized glutathione; IL: interleukin; I/R: ischemia and reperfusion; MDA: malondialdehyde; N/A: not available; SBP: systolic blood pressure; TKA: total knee arthroplasty; TQ: tourniquet; XO: xanthine oxidase.

4. Effects of TQ-Induced I/R Injury on Remote Organs

The I/R of the lower extremity affects not only the local structures but also distant organs. The remote response to I/R is associated with microvascular dysfunction [23]. Activated endothelial cells produce excessive ROS at the initiation of reperfusion and lead to an imbalance between superoxide and nitric oxide in all segments of the microcirculation, which subsequently induce a systemic inflammatory response and cause multiple organ damage. A previous study [29] reported hepatic and renal dysfunction as well as pulmonary damage in animals subjected to three hours of bilateral hind limb ischemia, followed by three hours of reperfusion. In relation to TQ-induced I/R in the clinical setting, remote kidney damage was suggested by the elevation of two sensitive indicators of proximal tubular function [30]. However, no significant myocardial, cerebral, or lung injury was demonstrated after unilateral TKA surgery [31-33]. It is likely that the severity of distant organ injury is related to the degree of local tissue injury and systemic inflammatory activation. This supposition is supported by higher postoperative complications affecting multiple organ systems among bilateral TKA patients compared to those undergoing a unilateral TKA [34]. A comprehensive summary of these findings is shown in Table 3.
Table 3

Effects of TQ-induced I/R injury on remote organs.

Sample size/ageTQ pressure/ischemia timeMain findings (compared to baseline level)InterpretationReferences
Outcomes on remote organSystemic effects
n = 16/70 ± 4 yr91 ± 11 min, N/AHeart:↔ CPK-MB↔ Troponin I↑ serum MDANo cardiac muscle injury after TKA with TQ[31]
n = 36/71 ± 7 yrN/ABrain:↔ rScO2No POCD at 1 weekLungs:↔ PF ratioKidney:↔ serum Cr↑ plasma lactate↑ serum CPK↔ serum LDH, AST↔ serum IL-6, TNF-α, IL-10↓ serum TNF-βNo adverse effects on regional cerebral oxygenation, pulmonary oxygenation, and renal function after TKA with TQ[32]
n = 17/67 ± 10 yr250 mmHg, 52 ± 11 minLungs:↔ urine desmosine/Cr ratio↑ serum IL-6, TNF-α, CRP, and WBC countNo lung injury occurred as indicated by the unaltered marker of elastin breakdown after TKA with TQ[33]
n = 15/64–73 yr300–350 mmHg, 83–121 minKidney:↑ urine α-1-microglobulin/Cr ratio↑ urine GST-α/Cr ratio↔ urine NAG/Cr ratio↓ serum cystatin C↓ serum Cr and urea↑ plasma lactate↑ serum myoglobin↑ serum lactoferrinPossible proximal tubular injury after TKA with TQ[30]

AST: aspartate aminotransferase; CPK: creatinine phosphokinase; CRP: c-reactive protein; Cr: creatinine; GST-α: glutathione-S-transferase-α; IL: interleukin; LDH: lactate dehydrogenase; MDA: malondialdehyde; N/A: not available; NAG: N-acetyl-β-D-glucosaminidase; PF ratio: ratio of arterial oxygen partial pressure to fractional inspired oxygen; POCD: postoperative cognitive dysfunction; rScO2: regional cerebral oxygen saturation; TKA: total knee arthroplasty; TNF: tumor necrosis factor; TQ: tourniquet; WBC: white blood cell.

5. Effects of Ischemic Conditioning on TQ-Induced I/R Injury in TKA

Ischemic preconditioning (IPC) is an exposure of tissues to one or more brief periods of I/R which generates small amounts of free radicals resulting in an adaptive response to subsequent prolonged ischemic stress and reperfusion injury [35]. The IPC results in protection, consisting of two phases, an early phase and a late phase [23, 36]. The early phase affects ion channel permeability, posttranslational modification of proteins, and release of autocoids such as adenosine, bradykinin, and nitric oxide. The later phase is dependent on the gene expression and de novo protein synthesis involved in endothelial function, an inflammatory response, and hemostasis. During the conditioning, the released autocoids bind to G-protein-coupled receptors (GPCRs) which subsequently activate growth factor receptors (GFRs) and in addition stimulate intracellular kinase pathways. These processes result in an increase in antiapoptotic proteins, inhibition of proapoptotic proteins, translocation of transcription factors, opening of ATP-sensitive potassium channels (KATP), and inhibition of the mitochondrial permeability transition pores (mPTPs). The IPC of the lower extremity in unilateral TKA patients showed protective genomic responses, which resulted in an upregulated expression of immediate early response genes, oxidative stress defense genes and prosurvival genes, and regulation of neuron apoptosis [37, 38]. However, the systemic inflammatory signals were not suppressed by IPC performed with one to three cycles of five-minute ischemia and five-minute reperfusion [33, 37, 39]. A comprehensive summary of these findings is shown in Table 4.
Table 4

Effects of ischemic preconditioning (IPC) and remote IPC (rIPC) on TQ-induced I/R injury in TKA.

Study model/specimen/TQ pressureIPC protocol/TQ ischemia time/sample size/ageMain findings (compared to control)InterpretationReferences
InterventionControlClinical outcomeMechanism
RCT/antecubital venous blood, quadriceps muscle biopsy, SBP + 100 mmHg3 cycles of 5 min ischemia and 5 min reperfusion at operated thigh, 68–87 min, n = 10no IPC, 68–87 min, n = 10N/A↑ gene expression(i) immediate early response genes(ii) oxidative stress defense genes(iii) mitochondrial genes(iv) prosurvival genes↓ gene expression(i) proapoptotic genes↔ serum IL-6, CRP, ESR, and WBC countIPC induced a protective genomic responseIPC did not prevent systemic inflammatory response[37]
Case-control study/quadriceps muscle biopsyN/A, n = 4No IPC, n = 4N/AAltered expression of genes involved in neurological system process and regulation of neuron apoptosisIPC induced a protective genomic response[38]
RCT/venous blood, urine/250 mmHg1 cycle of 5 min ischemia and 5 min reperfusion at operated thigh, 58 ± 11 min, n = 17, 67 ± 11 yrno IPC, 52 ± 11 min, n = 17, 67 ± 10 yr↓ median pain scores within 48 h after surgery↔ postoperative analgesic consumption↓ length of hospital stay↔ serum IL-6, TNF-α, CRP, and WBC count↔ urine desmosine/Cr ratioIPC did not prevent systemic inflammatory response or the level of lung injuryIPC may improve postoperative pain control[33]
RCT/venous blood, blood from surgical drain/250 mmHg1 cycle of 5 min ischemia and 5 min reperfusion at operated thigh, 48 min (IQR 13), n = 30, 67 yr (IQR 10.8)no IPC, 54 min (IQR 18), n = 30, 72.5 yr (IQR 13)↓ pain scores within 48 h after surgery↔ postoperative analgesic consumption↔ physical therapy parameters↔ length of hospital stay↔ intraarticular IL-6, TNF-α↔ systemic prothrombotic levelsIPC may improve postoperative pain controlHypercoagulative state occurred after TKA surgery using TQ application[39]
RCT/arterial blood, venous blood/double SBP mmHg3 cycles of 5 min ischemia at nonoperated thigh, n = 36, 69 ± 7 yrNo IPC, n = 36, 71 ± 7 yrBrain:↑ rScO2↔ POCD at 1 weekLungs:↑ PF ratio↓ serum LDH↔ serum CPK and AST↔ serum IL-6, TNF-α, IL-10, and TNF-βRemote IPC improved regional cerebral and pulmonary oxygenation possibly via a decrease in tissue damage[32]
Cross-sectional study/venous blood/double SBP mmHgApprox. 60 min ischemia at previously operated thigh, 62 ± 19 min, n = 12, 67 ± 5 yrFirst-operated knee, 63 ± 14 min, n = 12, 67 ± 5 yrN/ATend to ↓ whole blood ROS production↔ plasma PCOOHRemote IPC may occur during bilateral TKA with sequential application of TQ[42]
Cross-sectional study/venous bloodApprox. 90 min ischemia at previously operated thigh, 89 ± 9 min, n = 16, 70 ± 4 yrFirst-operated knee, 91 ± 11 min, n = 16, 70 ± 4 yrN/ATend to ↓ serum MDARemote IPC may occur during bilateral TKA with sequential application of TQ[31]
Cross-sectional study/venous blood (dorsum of each foot)/double SBP mmHgApprox. 60 min ischemia at previously operated thigh with 20 min reperfusion, 62 ± 19 min, n = 30, 64 ± 5 yrFirst-operated knee (right), 61 ± 5 min, n = 30, 64 ± 5 yrMuscle:↔ WOMAC scores (assessment of joint pain, stiffness, and function) at 1 month↔ serum MDA↔ serum LDHSequential ischemic surgical procedure did not reduce oxidative injury after reperfusion[43]

AST: aspartate aminotransferase; CPK: creatinine phosphokinase; CRP: c-reactive protein; Cr: creatinine; IL: interleukin; ESR: erythrocyte sedimentation rate; IPC: ischemic preconditioning; I/R: ischemia and reperfusion; IQR: interquantile range; LDH: lactate dehydrogenase; MDA: malondialdehyde; N/A: not available; PCOOH: phosphatidylcholine hydroperoxide; PF ratio: ratio of arterial oxygen partial pressure to fractional inspired oxygen; POCD: postoperative cognitive dysfunction; RCT: randomized controlled trial; ROS: reactive oxygen species; rScO2: regional cerebral oxygen saturation; SBP: systolic blood pressure; TKA: total knee arthroplasty; TNF: tumor necrosis factor; TQ: tourniquet; WBC: white blood cell; WOMAC: Western Ontario and McMaster University Osteoarthritis Index.

Remote ischemic preconditioning (rIPC) is the conditioning applied to distant tissues or organs in order to render tissues with a subsequent sustained ischemic episode resistant to I/R injury. The potential mechanisms of rIPC consist of two components which are humoral and neural [40, 41]. The two hypotheses involve production of endogenous substrates, such as adenosine, bradykinin, and calcitonin gene-related peptides (CGRP) in the remote ischemic tissues. These endogenous mediators enter the bloodstream and initiate protective effects via their respective receptors in other tissues. In a different way, these substrates stimulate afferent nerve fibers and transmit protection to distant organs through efferent nerve fibers. Thus, an intact neural pathway is required for the complete signaling of remote preconditioning. The skeletal muscle ischemia resulting from use of a TQ on a nonoperated thigh has been investigated in the TKA setting. This rIPC with three cycles of five-minute ischemia improved regional cerebral and pulmonary oxygenation during the early reperfusion period in the patients undergoing unilateral TKA under general anesthesia [32]. However, in cases of bilateral TKA, application of a thigh TQ in the first-operated knee may prevent I/R injury from occurring during the subsequent ischemic surgical procedure on the other knee [31, 42, 43]. Nonetheless, the conditioning stimulus of rIPC in these previous studies was unclear. The ischemic times of the preconditioning, of approximately 60–90 minutes, were longer than a typical ischemic stimulus of IPC. It is uncertain whether a longer conditioning time is more effective than a conventional time [44]. It is noteworthy that the anesthesia technique should be focused because spinal anesthesia can block neural impulses at spinal nerve roots and may interfere with the neural pathway of rIPC. A comprehensive summary of these findings is shown in Table 4.

6. Effects of Anesthetic Agents on TQ-Induced I/R Injury in TKA

Anesthetic intervention to reduce TQ-related I/R injury in cases of orthopedic surgery has been systematically reviewed [8]. Anesthetic agents with proven antioxidative effects include propofol, dexmedetomidine, and ketamine. Intravenous propofol (2,6-diisopropylphenol) is a common choice as an anesthetic agent for sedation and maintenance of anesthesia. Its antioxidative properties arise from its chemical structure which is similar to the endogenous antioxidant α-tocopherol and phenol-based free radical scavengers [45]. The cardioprotective effect of propofol in cases of cardiac I/R is dose-dependent and mediated by the activation of mitochondrial respiratory chain complexes [46, 47]. However, in skeletal muscle I/R, the small or sedation dose of propofol (2 mg/kg/h) infused throughout the operation demonstrated antioxidant and anti-inflammatory properties [48, 49]. Sevoflurane and other halogenated volatile anesthetics have shown protective effects on the myocardium after cardiac I/R [50]. However, the antioxidative effect of sevoflurane and halothane were less than intravenous propofol in this skeletal muscle I/R setting [51, 52]. Therefore, a reasoned anesthetic technique for TKA with TQ is a combined spinal anesthesia with small-dose propofol infusion [48, 49, 51–53]. A role of peripheral nerve blockade for post-TKA pain control has received increasing attention, but its effects on oxidative stress and inflammatory responses have not been investigated. A comprehensive summary of these findings is shown in Table 5.
Table 5

Effects of anesthetic agents on TQ-induced I/R injury in TKA.

Study model/specimen/TQ pressureAnesthetic agent/dose/TQ ischemia time/sample size/ageMain findings (compared between groups)InterpretationReferences
InterventionControlClinical outcomeMechanism
RCT/venous blood/350 mmHgPropofol, 2 mg/kg/h, 90 ± 7 min, n = 18, 66 ± 7 yrNormal saline, 0.2 ml/kg/h, 93 ± 10 min, n = 17, 69 ± 10 yrSedation effectPropofol > controlPlasma SOD, TCAPropofol > controlSerum MDA, hsCRP, and blood neutrophil countPropofol < controlSedation dose of propofol has antioxidative and anti-inflammatory properties[48]
RCT/arterial blood/double SBP mmHgPropofol, 0.2 mg/kg then 2 mg/kg/h, 72 ± 18 min, n = 11, 67 ± 5 yrMidazolam, 5 mg, 69 ± 14 min, n = 11, 63 ± 7 yrN/AWhole blood ROS productionPropofol < midazolamSedation dose of propofol attenuates ROS production compared to midazolam[49]
RCT/venous bloodPropofol, 2–2.5 mg/kg then 6–10 mg/kg/h, 79 ± 13 min, n = 10, 70 ± 6 yrSevoflurane, 1.5–2%, 83 ± 15 min, n = 10, 69 ± 5 yrN/ASerum MDAPropofol < sevofluranePropofol reduces oxidative injury in the TQ-induced I/R model[51]
RCT/arterial blood, venous blood/350–400 mmHgPropofol, 2 mg/kg then 4–8 mg/kg/h, 114 ± 19 min, n = 15, 69 ± 6 yrHalothane, 0.7–1%, 116 ± 25 min, n = 15, 66 ± 5 yrMAP, pH, PaO2, PaCO2Propofol ↔ halothaneSerum MDAPropofol < halothanePropofol reduces oxidative injury in the TQ-induced I/R model[52]

hsCRP: high-sensitivity C-reactive protein; I/R: ischemia and reperfusion; MAP: mean arterial pressure; MDA: malondialdehyde; N/A: not available; PaCO2: arterial carbon dioxide partial pressure; PaO2: arterial oxygen tension; RCT: randomized controlled trial; ROS: reactive oxygen species; SBP: systolic blood pressure; SOD: superoxide dismutase; TAC: total antioxidative capacity; TQ: tourniquet.

7. Effects of Pharmacological Intervention on TQ-Induced I/R Injury in TKA

ROS from the TQ-related I/R can be modulated by antioxidants. The antioxidants may reduce the cellular level of oxygen free radicals either by inhibiting ROS production, enhancing antioxidant enzymes, or reacting with the free radical intermediates in chain reactions [54]. Besides the antioxidants, interventions preventing mitochondrial dysfunction and local and systemic inflammation processes possibly play an important role in skeletal muscle I/R protection. Previous studies [11, 30, 31, 53, 55] concerning the preventive effects of vitamin C, mannitol, N-acetylcysteine (NAC), inhaled nitric oxide (iNO) and a low concentration of oxygen on I/R injury following TKA have been investigated. Vitamin E and vitamin C are natural nonenzymatic antioxidants that effectively scavenge lipid peroxyl radicals and terminate the lipid peroxidase chain reaction [56]. Administrated intravenously for ten minutes before TQ deflation and 20 minutes after reperfusion, high-dose vitamin C significantly reduced serum malondialdehyde (MDA) levels, a toxic metabolite of lipid peroxidation. Furthermore, vitamin C showed protective effects on the myocardium by significantly reducing troponin I levels at eight hours after the operation compared to the level observed in the controls [31]. Mannitol, a scavenger of hydroxyl free radicals, did not decrease the effects of reperfusion injury on skeletal muscle [11] although a dose-dependent attenuation of oxidative stress induced lung injury following liver I/R has been reported [57]. The exogenous administration of NO lessened the reperfusion inflammatory response in knee surgery patients having general anesthesia [58]. However, with the spinal anesthesia technique, neither local nor systemic signs of endothelial cell activation or inflammatory response were detected at two hours after TQ release. Therefore, the presence of intraoperative iNO did not have a positive effect in this setting [55]. A lower oxygen tension during spinal anesthesia may be an explanation because the formation of isofurans, a free radical mediated peroxidation of arachidonic acid, increased concomitantly with elevated O2 concentrations occurring during general anesthesia [53]. Regarding NAC, it is a direct precursor to glutathione (GSH) which directly scavenges ROS and indirectly supports GSH peroxidase [59]. The beneficial effect of NAC on TQ-related I/R injury has been reported [60, 61]. However, a high dose of NAC significantly increased urine markers indicating renal tubular damage [30]. Therefore, techniques of administration including optimal dose, route, and timing of pharmacological interventions should be carefully validated in the skeletal muscle I/R model. A comprehensive summary of these findings is shown in Table 6.
Table 6

Effects of pharmacological intervention on TQ-induced I/R injury in TKA.

Study model/specimen/TQ pressureDrug/dose/TQ ischemia time/sample size/ageMain findings (compared between groups)InterpretationReferences
InterventionControl
RCT/venous bloodVitamin C, 0.03 g/kg during ischemia then 0.01 g/kg after reperfusion, 91 ± 11 min, n = 16, 71 ± 4 yrNormal saline, 91 ± 14 min, n = 16, 70 ± 4 yrSerum MDASerum troponin IVitamin C group < controlHigh-dose vitamin C prevents oxygen free radical production and may have myocardial protection properties[31]
RCT/vastus lateralis muscle biopsy/double SBP mmHgMannitol, 930 mosmol/kg, 12.5 mL/kg/day, 75–93 min, n = 8, 64–74 yr5% glucose, 18.75 mL/kg/day, 50–88 min, n = 7, 62–79 yrMuscle GSH, tGSHMuscle amino acidMannitol group ↔ controlNo positive effects of mannitol in this TQ-induced I/R model[11]
RCT/venous blood, quadriceps femoris muscle biopsy/300 mmHgiNO, 80 ppm entire operation, 101 ± 20 min, n = 15, 63 ± 14 yrPartial iNO,80 ppm during operation except ischemia period, 103 ± 19 min, n = 15, 65 ± 9 yrNitrogen, 95 ± 19 min, n = 15, 64 ± 9 yrPlasma ICAM, VCAMPlasma P-selectin, E-selectinCD68+ macrophage expressionExpression of ICAM, VCAM, P-selectiniNO, partial iNO groups ↔ controlNo beneficial effects of iNO in this TQ-induced I/R model[55]
RCT/antecubital venous blood/200 mmHgLower O2 tension, FiO2 = 0.4, 61–110 min, n = 19, 66–77 yrHigher O2 tension, FiO2 = 0.5, 86–107 min, n = 20, 62–74 yrPlasma isofuransLower FiO2 < higher FiO2Elevated O2 tension during general anesthesia reflects increased oxidative stress[53]
RCT/venous blood, urine/300–350 mmHgNAC, 150 mg/kg before ischemia then 6.25 mg/kg/h during ischemia, 77–113 min, n = 15, 62–77 yr5% glucose, 83–121 min, n = 15, 64–73 yrUrine α-1-microglobulin/Cr ratioUrine NAG/Cr ratioUrine myoglobinNAC group > controlHigh-dose NAC may aggravate proximal tubular injury[30]

Cr: creatinine; FiO2: fraction of inspired oxygen; GSH: reduced glutathione; ICAM: intercellular adhesion molecule; iNO: inhaled nitric oxide; I/R: ischemia and reperfusion; MDA: malondialdehyde; NAC: N-acetylcysteine; NAG: N-acetyl-β-D-glucosaminidase; RCT: randomized controlled trial; tGSH: total glutathione; TQ: tourniquet; VCAM: vascular adhesion molecule.

8. Conclusions

Use of a TQ during TKA resulted in skeletal muscle I/R injury to localized skeletal muscle, systemic circulation, and distant organs. In the skeletal muscle, changes in protein metabolism suggest inhibition of protein synthesis and enhancement of protein breakdown. During I/R, genes related to the cell stress pathways are upregulated in skeletal muscle cells without evidence of mitochondrial dysfunction. In terms of circulation, oxidative injuries and inflammatory responses are more intense in the reperfused area than in the systemic circulation. As regards remote organs, no significant myocardial, cerebral, or lung injuries were reported but the renal proximal tubular function was impaired. Several studies investigated the protective effects of IPC, anesthetic agents, and other pharmacological interventions. Sedative doses of propofol have antioxidative and anti-inflammatory properties. However, biochemical outcomes of the use of IPC and other medication to prevent I/R damage were diversified depending on the technique of administration. The optimal technique of therapeutic interventions and the biochemical results thereof should be further verified and correlated to clinical outcomes after TKA. The effects of TQ-induced I/R injury on localized skeletal muscle, circulation, and remote organs and the effects of therapeutic interventions on the skeletal muscle I/R in TKA are summarized in Figure 1.
Figure 1

Effects of tourniquet- (TQ-) induced I/R injury on localized skeletal muscle, circulation, and remote organs and the effects of therapeutic interventions on the skeletal muscle I/R in cases of surgery for knee arthroplasty (TKA). The skeletal muscle I/R condition results in (1) preserved cellular bioenergy and mitochondrial function, (2) upregulation of genes related to cell stress pathways, (3) endothelial dysfunction as indicated by an increase in endothelin 1 and NOS levels, (4) alteration in protein metabolism, (4) increased oxidative stress and inflammatory responses, and (5) injury to distant organs including the kidney. Ischemic preconditioning (IPC), propofol, and vitamin C demonstrated positive or protective effects in the cases of I/R injury in this setting, while elevated O2 tension aggravated the injury and N-acetylcysteine may have dose-dependent responses. Other interventions including remote ischemic preconditioning (rIPC), volatile anesthetic agents, mannitol, and nitric oxide possibly produce positive outcomes, and additional studies in this I/R condition should be investigated. ⊕: positive effect; ⊖: negative effect; ?: inadequate evidence; ↑: increase; ↓: decrease; ↔: no change; ATP: adenosine triphosphate; CPK-MB: creatinine phosphokinase-MB; Cr: creatinine; eNOS: endothelial nitric oxide synthase; nNOS: neuronal nitric oxide synthase; O2: oxygen.

  59 in total

Review 1.  Is a tourniquet beneficial in total knee replacement surgery? A meta-analysis and systematic review.

Authors:  Toby O Smith; Caroline B Hing
Journal:  Knee       Date:  2009-07-19       Impact factor: 2.199

2.  Oxidative stress induced by bloodless limb surgery on humans.

Authors:  E Karg; I Németh; G Virág; T Mészáros; D Boda; S Pintér
Journal:  Eur J Clin Invest       Date:  1997-12       Impact factor: 4.686

3.  Different oxidative stress marker levels in blood from the operated knee or the antecubital vein in patients undergoing knee surgery: a tourniquet-induced ischemia-reperfusion model.

Authors:  José García-de-la-Asunción; Amparo Perez-Solaz; Miguel Carrau; Francisco Javier Belda; Jaime Perez-Griera; Beatriz Garriges
Journal:  Redox Rep       Date:  2012-08-08       Impact factor: 4.412

4.  Effect of low-dose N-acetyl-cysteine infusion on tourniquet-induced ischaemia-reperfusion injury in arthroscopic knee surgery.

Authors:  F Saricaoglu; D Dal; A E Salman; O A Atay; M N Doral; M A Salman; K Kilinç; U Aypar
Journal:  Acta Anaesthesiol Scand       Date:  2005-07       Impact factor: 2.105

5.  Effects of spinal or general anesthesia on F₂-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery.

Authors:  Emilie Mas; Anne E Barden; Tomas B Corcoran; Michael Phillips; L Jackson Roberts; Trevor A Mori
Journal:  Free Radic Biol Med       Date:  2011-01-22       Impact factor: 7.376

6.  Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin.

Authors:  Giuseppe Paradies; Giuseppe Petrosillo; Marilva Pistolese; Nicola Di Venosa; Antonio Federici; Francesca Maria Ruggiero
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

7.  Mitochondrial involvement in propofol-induced cardioprotection: An in vitro study in human myocardium.

Authors:  Sandrine Lemoine; Lan Zhu; Steeve Gress; Jean-Louis Gérard; Stéphane Allouche; Jean-Luc Hanouz
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-08

Review 8.  Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.

Authors:  Gordon F Rushworth; Ian L Megson
Journal:  Pharmacol Ther       Date:  2013-09-28       Impact factor: 12.310

9.  The antioxidant potential of propofol (2,6-diisopropylphenol).

Authors:  P G Murphy; D S Myers; M J Davies; N R Webster; J G Jones
Journal:  Br J Anaesth       Date:  1992-06       Impact factor: 9.166

Review 10.  Ischaemic conditioning and reperfusion injury.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

View more
  21 in total

1.  The effect of tourniquet uses on total blood loss, early function, and pain after primary total knee arthroplasty: a prospective, randomized controlled trial.

Authors:  Hai-Yan Zhao; Releken Yeersheng; Xue-Wen Kang; Ya-Yi Xia; Peng-De Kang; Wen-Ji Wang
Journal:  Bone Joint Res       Date:  2020-06-30       Impact factor: 5.853

2.  [Effect of pneumatic tourniquet on perioperative blood loss in total knee arthroplasty].

Authors:  Ziqi Zhang; Jialin Liang; Xiaoli Zuo; Ruiyu Liu; Xiaoqian Dang; Kunzheng Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-06-15

Review 3.  Impact of tourniquet during knee arthroplasty: a bayesian network meta-analysis of peri-operative outcomes.

Authors:  Filippo Migliorini; Nicola Maffulli; Paolo Aretini; Andromahi Trivellas; Markus Tingart; Jörg Eschweiler; Alice Baroncini
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-08       Impact factor: 3.067

4.  The Role of Melatonin in Electroacupuncture Alleviating Lung Injury Induced by Limb Ischemia-Reperfusion in Rabbits.

Authors:  Shu-An Dong; Li-Rong Gong; Jian-Bo Yu; Yong-Xing Kan
Journal:  Med Sci Monit       Date:  2020-05-19

5.  Protective Effects of Rocuronium Bromide on Ischemia-Reperfusion Injury in Skeletal Muscle Induced by Tourniquet in Patients Undergoing Elective Unilateral Total Knee Arthroplasty: A Prospective, Double Blind, Randomized, Controlled Study.

Authors:  Hui Chen; Jing-Qiu Wei; Yi-Wen Wang; Kun-Peng Zhou; Ying He; He Liu; Yue-Ying Zhang
Journal:  Drug Des Devel Ther       Date:  2020-08-18       Impact factor: 4.162

6.  Tourniquet use in routine primary total knee arthroplasty is associated with a higher transfusion rate and longer postoperative length of stay: a real-world study.

Authors:  Hong Xu; Jingli Yang; Jinwei Xie; Zeyu Huang; Qiang Huang; Guorui Cao; Fuxing Pei
Journal:  BMC Musculoskelet Disord       Date:  2020-09-18       Impact factor: 2.362

7.  Reperfusion Interval as a Prevention of Lung Injury Due to Limb Ischemia-Reperfusion After Application of Tourniquet in Murine Experimental Study.

Authors:  Thomas Erwin Christian Junus Huwae; Agung Riyanto Budi Santoso; Wongso Kesuma; Hidayat Sujuti; Retty Ratnawati; William Putera Sukmajaya; Mohammad Hidayat
Journal:  Indian J Orthop       Date:  2020-04-07       Impact factor: 1.251

8.  A comparison of thrombosis in total knee arthroplasty with and without a tourniquet: a meta-analysis of randomized controlled trials.

Authors:  Jia Xie; Hao Yu; Fangyuan Wang; Juehua Jing; Jun Li
Journal:  J Orthop Surg Res       Date:  2021-06-25       Impact factor: 2.359

9.  MicroRNA-153-3p increases autophagy in sevoflurane-preconditioned mice to protect against ischaemic/reperfusion injury after knee arthroplasty.

Authors:  Shuang Qiu; Benjuan Liu; Yanshuai Mo; Xueqin Wang; Lina Zhong; Xiao Han; Fuli Mi
Journal:  J Cell Mol Med       Date:  2020-04-02       Impact factor: 5.310

10.  Impact of Dexmedetomidine on Tourniquet-Induced Systemic Effects in Total Knee Arthroplasty under Spinal Anesthesia: a Prospective Randomized, Double-Blinded Study.

Authors:  Cheol Lee; Cheolhyeong Lee; Cheolhwan So; Jiheui Lee; Insung Choi; Xiao Ma; Jihyo Hwang
Journal:  Biomed Res Int       Date:  2020-10-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.